Showing 1 - 2 results of 2 for search 'Kris L L Movig', query time: 0.02s
Refine Results
-
1
Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar by Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Thijs J. Giezen
Published 2023-09-01
Article -
2